HKD 0.64
(1.59%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 93.66 Million HKD | 28.98% |
2022 | 67.63 Million HKD | 74.01% |
2021 | 40.38 Million HKD | 588.71% |
2020 | 5.86 Million HKD | 241.47% |
2019 | -4.14 Million HKD | -142.51% |
2018 | 9.75 Million HKD | -58.25% |
2017 | 23.35 Million HKD | 21.92% |
2016 | 19.15 Million HKD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q2 | 12.38 Million HKD | -7.77% |
2023 Q4 | 27.65 Million HKD | 0.0% |
2023 FY | - HKD | 28.98% |
2023 Q1 | 13.43 Million HKD | -51.54% |
2023 Q3 | 27.65 Million HKD | 123.2% |
2022 Q1 | 12 Million HKD | 294.27% |
2022 Q3 | 13.49 Million HKD | -6.4% |
2022 FY | - HKD | 74.01% |
2022 Q2 | 14.41 Million HKD | 20.04% |
2022 Q4 | 27.71 Million HKD | 105.42% |
2021 FY | - HKD | 588.71% |
2021 Q4 | -6.18 Million HKD | -144.48% |
2021 Q3 | 13.89 Million HKD | -11.84% |
2021 Q2 | 15.76 Million HKD | -6.77% |
2021 Q1 | 16.9 Million HKD | 268.75% |
2020 FY | - HKD | 241.47% |
2020 Q1 | 3.04 Million HKD | 129.52% |
2020 Q2 | -2 Million HKD | -165.94% |
2020 Q4 | 4.58 Million HKD | 1786.83% |
2020 Q3 | 243 Thousand HKD | 112.11% |
2019 Q2 | -483 Thousand HKD | -105.24% |
2019 FY | - HKD | -142.51% |
2019 Q4 | -10.3 Million HKD | -301.25% |
2019 Q3 | -2.56 Million HKD | -431.68% |
2019 Q1 | 9.21 Million HKD | 3.23% |
2018 Q4 | 8.92 Million HKD | 153.18% |
2018 Q3 | 3.52 Million HKD | 1570.14% |
2018 Q2 | 211 Thousand HKD | 107.26% |
2018 Q1 | -2.9 Million HKD | -156.92% |
2018 FY | - HKD | -58.25% |
2017 FY | - HKD | 21.92% |
2017 Q4 | 5.1 Million HKD | -36.93% |
2017 Q3 | 8.09 Million HKD | 68.61% |
2017 Q2 | 4.8 Million HKD | 0.0% |
2017 Q1 | 4.8 Million HKD | 0.0% |
2016 FY | - HKD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Anxian Yuan China Holdings Limited | 106.4 Million HKD | 11.975% |
Water Oasis Group Limited | 345.33 Million HKD | 72.878% |
Miricor Enterprises Holdings Limited | 86.61 Million HKD | -8.13% |
Perfect Medical Health Management Limited | 577.56 Million HKD | 83.783% |